OINDPnews


Proveris Scientific

Products and Services

One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza

The One Drop diabetes management platform has agreed to integrate MannKind’s BluHale inhaler monitoring device for the Afrezza insulin DPI, the companies said. The integration of the BluHale device will allow for monitoring of insulin doses, glucose forecasts, and other services for patients using the Afrezza inhaler.  MannKind Corporation CEO Michael Castagna … [Read more...] about One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza

Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy

Kurve Technology has announced that Seurat Therapeutics will use Kurve's intranasal delivery technology for Seurat's IGF-1 nasal aerosol for the treatment and prevention of migraines. Details of the development and collaboration agreement were not disclosed. In October 2018, Seurat announced that it had received a ~$510,000 grant from the National Institute of … [Read more...] about Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy

Proveris Scientific adds Stephen McDonald to its European support team

Proveris Scientific announced that Stephen McDonald has joined the company's European team, which is based in the UK. McDonald, who has previously worked with Proveris to provide customer support as an independent contractor, will work with European Sales Director Deborah Jones providing customer service support for Europe and the Middle East. McDonald has more … [Read more...] about Proveris Scientific adds Stephen McDonald to its European support team

Study demonstrates feasibility of inhaled lipid cisplatin delivery via Windtree’s ADS

Windtree Therapeutics and Eleison Pharmaceuticals have announced results from a study that demonstrated the feasibility of delivering Eleison's inhaled lipid cisplatin (ILC) via Windtree's Aerosol Delivery System (ADS). In March 2018, the companies announced that they had partnered for development of ILC for the treatment of lung cancer. According to the … [Read more...] about Study demonstrates feasibility of inhaled lipid cisplatin delivery via Windtree’s ADS

Clement Clarke launches Clip-Tone inhaler feedback device

Clement Clarke has announced the launch of its Clip-Tone technique guidance whistle for use with GSK's Evohaler Ventolin and Seretide MDIs in the UK. The Clip-Tone will be available by prescription only. Like the company's Flo-Tone inhaler training device, the Clip-Tone provides audio feedback when the patient inhales at the correct inhalation rate, with the tone … [Read more...] about Clement Clarke launches Clip-Tone inhaler feedback device

Particle Sciences gets authorization for manufacturing of Schedule I drugs

CDMO Particle Sciences is now registered with the US Drug Enforcement Administration (DEA) as a manufacturer of Schedule I substances, which means that the company can now provide development and manufacturing services for pharmaceutical cannabinoid products. The company points out that it has long been developing and manufacturing Schedule II-V drugs, including … [Read more...] about Particle Sciences gets authorization for manufacturing of Schedule I drugs

Inhalation Sciences announces plans to validate its PreciseInhale instrument for clinical use

Inhalation Sciences (ISAB) has announced that it will divest 40,000 shares of its subsidiary Ziccum AB in order to finance a study to validate its PreciseInhale dosing system for clinical use. The company said that it anticipates achieving technical and regulatory validation in approximately 15 months. PreciseInhale, which can produce aerosols at a specified dose … [Read more...] about Inhalation Sciences announces plans to validate its PreciseInhale instrument for clinical use